FDA approves HIV medication Lenacapavir, but it's costly

By Jonathan Lambert

Published June 24, 2025 at 4:14 AM EDT

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.

Jonathan Lambert

See stories by Jonathan Lambert

Support nonprofit, fact-based public service journalism

WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.

Contribute now

Related Content

NPR News

Breaking another presidential norm, Trump drops the f-bomb on camera

Tamara Keith

Presidents have been known to use salty language behind closed doors. But President Trump may be the first to very deliberately drop an f-bomb on camera.
NPR News

Fired Justice Department lawyer accuses agency of planning to defy court orders

Carrie Johnson

The accusations from a veteran government lawyer add to broader concern about the Trump administration's repeated clashes with the judiciary.
NPR News

Israel and Iran's fragile ceasefire. And, what to know about NYC's mayoral race

Brittney Melton

President Trump announced that a ceasefire has been established between Israel and Iran, but strikes continued as it was set to take place. And, what to know about NYC's mayoral race.
NPR News

She hoped key research could help save her eyesight. Then the Trump funding cuts came

Craig LeMoult

Jessica Chaikof says research into gene therapies could someday save her eyesight. But she worries cuts to federal research funding could mean that therapy won't be ready in time.
NPR News

6 new books out this week, including true stories of trailblazers

Colin Dwyer

But for many working adults, the summer can often feel the same as the rest of the year. So, maybe our idea of a "summer read" should encompass a wider swath of books? Here are a few out this week.